SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $62 | -99.9% | 3,688 | -10.0% | 0.00% | 0.0% |
| Q3 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $70,000 | +2233.3% | 4,098 | +1889.3% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 206 | -17.6% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 250 | -7.1% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 269 | +31.9% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 204 | +30.8% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 156 | -1.9% | 0.00% | – |
| Q3 2019 | $1,000 | -87.5% | 159 | -68.2% | 0.00% | – |
| Q3 2018 | $8,000 | +300.0% | 500 | +316.7% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 120 | +7.1% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 112 | +6.7% | 0.00% | – |
| Q3 2017 | $2,000 | – | 105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |